Neurol. praxi. 2021;22(6):481-486 | DOI: 10.36290/neu.2021.111

Driving motor vehicles in patients with epilepsy

doc. MUDr. Irena Doleľalová, Ph.D.1, JUDr. ©árka ©peciánová2, doc. MUDr. Jiří Hovorka, CSc.3, 4, MUDr. Jana Zárubová5, MUDr. Irena Novotná1, prof. MUDr. Petr Marusič, Ph.D.5, prof. MUDr. Milan Brázdil, Ph.D.1
1 Centrum pro epilepsie Brno, I. neurologická klinika, Fakultní nemocnice u sv. Anny a Lékařská Fakulta Masarykovy univerzity, Brno
2 Ústav veřejného zdravotnictví a medicínského práva 1. lékařské fakulty Univerzity Karlovy
3 Neurologie, Comfort Care, a. s., Praha
4 Neurologie a psychosomatické centrum Anděl Tulsia Clinic, s. r. o., Praha
5 Neurologická klinika 2. LF UK a FN Motol, Praha

The article presents current information on assessing the medical fitness to drive motor vehicles in persons with epilepsy. There are two driving licence categories: Category 1 (Groups A, B, B+E, AM, and subgroups A1 and B1) and Category 2 (professional drivers in Groups A, B, B+E, AM, subgroups A1 and B1; as well as C, C+E, D, D+E and T, C1, C1+E, D1, and D1+E). In Category 1, driving can be allowed after 12 months of being seizure-free if the patient is taking antiepileptic drugs, or after 6 months of being seizure-free if there was an isolated seizure and no treatment with antiepileptic drugs was commenced. In Category 2, driving can be allowed 10 years after complete withdrawal of antiepileptic drugs provided the patient has remained seizure-free. After an isolated seizure following which treatment with antiepileptic drugs was not initiated, driving can be allowed in 5 years. There are exceptions to the above-mentioned rules which are included in the present article. Some more complex situations are illustrated using case reports. Finally, a summary table is presented.

Keywords: driving licence, epilepsy, driving licence category 1, driving licence category 2.

Published: December 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doleľalová I, ©peciánová ©, Hovorka J, Zárubová J, Novotná I, Marusič P, Brázdil M. Driving motor vehicles in patients with epilepsy. Neurol. praxi. 2021;22(6):481-486. doi: 10.36290/neu.2021.111.
Download citation

References

  1. Beghi E, Carpio A, Forsrgen L, Hesdorffer DC, Malgrem K, Sander JW, Tomson T, Hauser WA. Recommendation for a definition of acute symptomatogenic seizures. Epilepsia 2010; 51(4): 671-675. Go to original source... Go to PubMed...
  2. Epilepsy and Driving in Europe A report of the Second European Working Group on Epilepsy and Driving, an advisory board to the Driving Licence Committee of the European Union. Final report; 3 April 2005.
  3. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J, Forsgren L, French JA, Glynn M, Hesdorffer DC, Lee BI, Mathern GW, Moshe SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S. ILAE official report: A practical clinical definition of epilepsy. Epilepsia 2014; 55(4): 475-82. Go to original source... Go to PubMed...
  4. Krijtová H, Krýsl D, Marusič P. Akutní symptomatické záchvaty a akutní symptomatický status epilepticus - definice, příčina a léčba. Neurol. praxi 2011; 12(4): 256-264.
  5. Marusič P. Změny v posuzování způsobilosti k řízení motorových vozidel u pacientů s epilepsií. Neurol. praxi 2010; 11(6): 432-433.
  6. Marusič P, Brázdil M, Hadač J, Hovorka J, Komárek V, Neąpor E, Vojtěch Z, Zárubová J. Soubor minimálních diagnostických standardů u pacientů s epilepsií. EpiStop 2017, dostupné na https://www.clpe.cz/soubory/Epistandardy_2017_web.pdf.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.